Liver Diseases  >>  Viramidine (taribavirin)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Viramidine (taribavirin) / Sanofi
NCT00230958: Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive

Completed
3
900
US
Viramidine, Ribavirin, pegylated interferon alfa-2b
Bausch Health Americas, Inc.
Chronic Hepatitis C
01/06
01/06
VISER2, NCT00093093 / 2004-000408-41: Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive

Completed
3
900
US, Canada, Europe, RoW
Viramidine, Ribavirin, pegylated interferon alfa-2a
Bausch Health Americas, Inc.
Chronic Hepatitis C
05/06
05/06

Download Options